BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6628505)

  • 1. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and disposition of sulfisoxazole in alcoholic cirrhosis.
    Cello JP; Oie S
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):1-12. PubMed ID: 4020620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
    Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
    Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.
    Pond SM; Tong T; Benowitz NL; Jacob P
    Aust N Z J Med; 1980 Oct; 10(5):515-9. PubMed ID: 6937164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucoregulatory response to insulin-induced hypoglycemia in Laennec's cirrhosis.
    Perez G; Trimarco B; Ungaro B; Rengo F; Saccà L
    J Clin Endocrinol Metab; 1978 May; 46(5):778-83. PubMed ID: 400562
    [No Abstract]   [Full Text] [Related]  

  • 14. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R; Bodemar G; Norlander B
    Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cimetidine after subchronic administration.
    Chin TW; Spino M; MacLeod SM; Mahon WA; Soldin SJ
    Eur J Clin Pharmacol; 1986; 30(6):741-4. PubMed ID: 3770069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cimetidine in patients with liver disease.
    González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.